Related Experiment Video
Updated: Feb 8, 2026

Author Spotlight: Replicating Human Osteosarcoma Progression in Immunodeficient Mice for Cancer Study
Published on: March 22, 2024
Decreased local and systemic levels of sFRP3 protein in osteosarcoma patients
Dalibel Bravo1, Ahmet Salduz1, Kristen L Shogren1
1Dept. of Orthopedic Surgery, Mayo Clinic, Rochester, MN, USA.
Abstract:
Osteosarcoma is a malignant bone tumor that occurs mainly in children and adolescents. Because Wnt signaling has been implicated in the pathogenesis of osteosarcoma, we have investigated the circulating and local levels of the Wnt antagonist protein, Secreted Frizzled Related Protein (sFRP) 3, in osteosarcoma patients. Enzyme linked immunosorbent assay (ELISA) analysis of 67 osteosarcoma and age-matched non-diseased control sera showed that sFPR3 protein levels were significantly lower in osteosarcoma than in normal. Analysis of tumor and adjacent normal tissues (9 pairs) from osteosarcoma patients showed a decrease in sFRP3 expression in 5 out of 9 tumor samples compared to normal tissues. Furthermore, immunohistochemical analysis of tissue microarray revealed a significant decrease in sFRP3 levels in tumor compared to normal bone. RNA sequencing analysis in osteosarcoma cells shows suppression of sFRP3 and concomitant expression of multiple Wnt family members mediating canonical or non-canonical Wnt signaling. Taken together, our findings show that the systemic and local levels of sFRP3 protein are downregulated in osteosarcoma and sFRP3 levels could be explored further in the diagnosis and the care of osteosarcoma patients.
Insights
Secreted Frizzled Related Protein 3 (sFRP3) levels are significantly lower in osteosarcoma patients. This downregulation of sFRP3 in both blood and tumor tissues suggests its potential role in osteosarcoma diagnosis and treatment.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Osteosarcoma is a prevalent bone cancer in children and adolescents.
- Wnt signaling pathways are recognized as crucial in osteosarcoma development.
- Secreted Frizzled Related Protein 3 (sFRP3) acts as a Wnt antagonist.
Purpose of the Study:
- To investigate the levels of sFRP3 in osteosarcoma patients.
- To determine the correlation between sFRP3 levels and osteosarcoma pathogenesis.
- To explore the diagnostic and therapeutic potential of sFRP3 in osteosarcoma.
Main Methods:
- Enzyme-linked immunosorbent assay (ELISA) for serum sFRP3 quantification.
- Analysis of tumor and adjacent normal tissues for sFRP3 expression.
- Immunohistochemical analysis of tissue microarrays.
- RNA sequencing of osteosarcoma cells.
Main Results:
- Serum sFRP3 protein levels were significantly lower in osteosarcoma patients compared to controls.
- Decreased sFRP3 expression was observed in 5 out of 9 tumor tissue samples.
- Immunohistochemistry confirmed reduced sFRP3 levels in tumor tissues versus normal bone.
- RNA sequencing revealed sFRP3 suppression and concurrent Wnt family member activation in osteosarcoma cells.
Conclusions:
- Systemic and local levels of sFRP3 protein are downregulated in osteosarcoma.
- sFRP3 downregulation is associated with Wnt signaling pathway alterations in osteosarcoma.
- sFRP3 represents a potential biomarker for osteosarcoma diagnosis and patient management.
Related Concept Videos
Decreasing Function
Decreased Body Temperature
Decreased pulse rate
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with...
Levels of Organization
Molecules Are Composed of Atoms, and Biomolecules Are Assembled from Molecules:
The most basic levels include atoms, molecules, and biomolecules. Atoms, the smallest unit of ordinary matter, are composed of a nucleus and electrons. Molecules...
Gram-negative Bacterial Protein Secretion Systems
Leveling Effect

